로딩 중...
52주 최고가 대비 55.8% 위치
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failure; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as Duchenne muscular dystrophy, multiple sclerosis, Alzheimer's disease, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. The company is headquartered in Bannockburn, Illinois.
SEC 13F 공시 기준 · 2026-Q1
SEC 13F 공시 기준 데이터입니다. 실제 현재 보유 현황과 다를 수 있으며, 투자 자문·권유·추천이 아닙니다.
| 재무 항목 | 2022년 | 2023년 | 2024년 | 2025년 |
|---|---|---|---|---|
| 주요 재무실적 (USD) | ||||
| 매출액 | $3.94B | $4.30B | $5.00B | $5.65B |
| 영업이익 | $240.2M | $314.6M | $321.8M | $337.9M |
| 당기순이익 | $150.6M | $267.1M | $211.8M | $207.6M |
| 잉여현금흐름 (FCF) | $232.2M | $329.4M | $287.8M | $217.1M |
| 수익성 비율 | ||||
| 영업이익률 | 6.1% | 7.3% | 6.4% | 6.0% |
| 순이익률 | 3.8% | 6.2% | 4.2% | 3.7% |
| ROE (자기자본이익률) | 10.9% | 18.8% | 15.1% | 15.7% |
| ROA (자산이익률) | 4.8% | 8.3% | 6.2% | 6.0% |
| 성장성 비율 | ||||
| 매출 성장률 (YoY) | - | 9.1% | 16.2% | 13.0% |
| EPS 성장률 (YoY) | - | 78.3% | -16.9% | 3.3% |
| 투자 지표 & 가치배수 | ||||
| PER (주가수익배수) | 34.8x | 21.1x | 25.1x | 26.8x |
| PBR (주가순자산배수) | 3.3x | 3.5x | 3.5x | 4.0x |
| PSR (주가매출배수) | 1.1x | 1.1x | 1.0x | 0.9x |
| FCF Yield | 5.1% | 6.7% | 5.9% | 4.1% |
| 재무 건전성 (안정성) | ||||
| 부채비율 (D/E) | 0.83 | 0.82 | 0.87 | 0.96 |
| 유동비율 | 1.76 | 1.77 | 1.70 | 1.53 |
MOLINA HEALTHCARE INC
$179.86
$9.4B